Takeda Pharmaceutical Co. and Eli Lilly & Co. won a more than a 99 percent cut in a $9 billion punitive damages award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine. Jurors properly found officials …
Takeda Pharmaceutical Co. Ltd said it would contest $6 billion in punitive damages imposed by a U.S. federal jury in a case alleging that Japan’s largest drugmaker had concealed cancer risks associated with its Actos diabetes drug. Eli Lilly and …
The maker of the world’s best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda …
